Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Becker’s Payer Issues Podcast

Becker’s Payer Issues Podcast artwork

Medicare Advantage, Value-Based Care and Improving Outcomes for Vulnerable Populations with Dr. Ken Cohen

Jul 8, 202623 minAudio
ShareXLinkedInFacebookWhatsAppEmail

In this episode, Dr. Ken Cohen, Chief Medical Officer at Optum Health, discusses new research on Medicare Advantage, social vulnerability, and how full-risk care models can improve quality, efficiency, and patient outcomes. He also shares insights on the infrastructure, technology, and strategies needed to advance value-based care.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

- GLP ones, Medicare Advantage Headwinds, a Medicaid landscape - that looks different - every quarter. - Their leadership right now means making durable decisions - in an environment that keeps moving, and the - organizations pulling ahead are the ones that stopped - waiting for stability - before acting. - Becker's fifth annual fall payer issues roundtable convenes - more than 500 - executive level attendees - and 70 plus speakers November second and third - at the Swiss Hotel Chicago. - Two days of senior level dialogue on affordability,

- benefit design, value based care, and the strategies - shaping how care gets financed - and delivered, featuring a celebrity keynote from pro - football hall of famer, Emmitt Smith. Agenda and - registration at beckerspayer.com. - Click events in the upper right. - Hello, everyone. This is Jacob Emerson with the - Becker's Payer Issues podcast. - Thrilled today to be joined by doctor Ken - Cohen, who serves as chief medical officer at - Optum Health. Doctor Cohen, thank you so much - for taking the time to be with me

- on the podcast today. Great to be with - you, Jacob. - Absolutely. Likewise, Ken, and, great to have you - back on the podcast with us. - We we've talked with you a lot in - the past, - about some of the research that you've done, - with with Optum and into the Medicare population. - But before we dive into your latest research, - hoping you could fill in our audience on - a little bit more about yourself, - your background in health care, and what it - is that you do today at Optum Health. - Happy to do that. So I'm an internist

- by training, spent my first ten years in - academics, - and the next twenty five years as the - chief medical officer of a large physician group - in Denver. For the past ten years, I've - served various roles within OptumHealth. And as you - noted, today, I'm the chief medical officer of - OptumHealth. - And and that's where the physicians and patients - live within Optum. - Optum Health is a national - medical group, comprised - of around 7,000 or so employed, - physicians

- and about 80,000 contracted physicians. - And we take care of 23,000,000 - patients and about 5,000,000 of those are in - full risk, fully accountable care contracts. - Wonderful. Well, appreciate some context there, Ken. So - I mentioned at the start of our conversation - that you you've got some new research out, - published in the June edition of the American - Journal of Managed Care, - and you looked at social vulnerability across at - risk Medicare Advantage, fee for service, - Medicare, and traditional Medicare,

- using the CDC social vulnerability index as a - proxy for social determinants of health. So, - tell our listeners - what ultimately was the most significant finding that - emerged from this this latest round of research - from you and and others, - that joined you? - Certainly. So the impact of social determinants - of health on health outcomes is a critical - issue, - and multiple studies suggest that this is a - major factor driving overall health outcomes. - For example, studies have been done showing marked

- differences in mortality just in adjacent zip codes, - and these differences are largely accounted for and - by social determinants. - With this latest study, our Optum Health Outcomes - Research Team - in collaboration with APG, America's Physician Groups, - has now published a total of five studies, - all of which unequivocally - established that when physicians and physician organizations - accept responsibility - for total cost of care and full risk - models, - that patients experience both improved quality and efficiency

- of care. - So to conduct these five studies, we amassed - a large dataset that included, 17 physician groups, - all members of APG, - over 15,000 - PCPs, - and over 5,000,000 patient years, coming from 35 - different health plans. - And this latest study - extended this research - by focusing on the population within Medicare and - Medicare Advantage - that had the highest levels of social vulnerability, - as you noted as measured by the SVI.

- That was a tool developed by the CDC - that scores census tracks across the country according - to levels of poverty, unemployment, - minority status, - types of housing, - and other factors that reflect, social determinants of - health. - And the first take home point from this - study is that the population of beneficiaries - in Medicare Advantage are more socially vulnerable than - those in traditional Medicare. - This analysis showed that nearly 68% of the - beneficiaries

- in full risk MA - and approximately sixty three percent of the beneficiaries - in fee for service MA - lived in areas with high levels of social - vulnerability, - which compared to only about fifty percent of - traditional Medicare beneficiaries. - And this is important because there has been - continued controversy - as to whether the MA population is more - ill and more costly - than the traditional Medicare population. - And these data confirm a higher level of - social vulnerability in the MA population,

- which we know is correlated with higher burden - of illness and higher cost of care. - Next point was, as in our four prior - studies, we demonstrated that full risk Medicare Advantage - was associated with significantly higher care quality and - efficiency - compared to traditional Medicare. - But what was unique about the study and - is the important take home point - is that if you focus on the beneficiaries - with the highest social vulnerability risk, - you see the greatest improvements in care quality - and efficiency

- comparing full risk MA to the traditional Medicare - population. - In other words, the higher the level of - social vulnerability, - the better the full risk MA model cares - for patients. - And the specific - examples of this that we derive from the - study - is if we look at acute inpatient hospital - admissions, for example, - there were 13% - fewer admissions in the less social vulnerable group, - but close to 17% - fewer admissions in the more socially vulnerable group.

- Looking at inpatient admissions through the emergency department - is one of the most important metrics we - have. And here there were 11% - fewer hospital admissions in the less socially vulnerable - group, but 14% - fewer admissions in the more socially vulnerable group. - And then looking at reducing the use of - high risk medications, - there was a 23% - lower use in the less socially vulnerable group, - but 30 lower use - in the more socially vulnerable group. Just three

- examples of how these data played out in - that study. - Understood. And I appreciate you laying that all - out for us, Ken, in a concise manner. - Basically, your your research is showing that the - gap between at risk Medicare Advantage and traditional - Medicare - has has widened for beneficiaries in high higher - vulnerability - areas, bigger reductions in admissions, ED visits, - high risk medication use than for lower vulnerability - beneficiaries. - It seems like then, you know, across your - body of research that you've done over the

- years, there's there's a theme that keeps emerging - around, - the the greater the social risk, the the - greater the differences in outcomes between care models. - So we've got a lot of health care - leaders listening in from a lot of different - parts of the industry. - Why is that finding significant for them specifically? - It's a great question, Jacob. - Health care leaders need to understand - that not only can this high needs population - be successfully

- managed in a fully accountable care model, - but the improvement in outcomes from this management - is even greater - than in other less vulnerable populations. - So this therefore represents not only an opportunity - for great health and social impact on these - patient lives, - but it's also a financially successful care model - when done well. - It's a double win. - However, it's not easy work and success isn't - guaranteed - because of the particular aspects of this population.

- So therefore, in order to be successful, you - need to first address the factors that drive - their health care utilization. - This includes a lack of primary care access, - lack of transportation, - behavioral health and substance use needs, - medication affordability - adherence, and food insecurity, just to name a - few. - In the full risk Medicare Advantage model, part - of the premium dollars saved from the sufficient - care management - can be redirected to build infrastructure - to manage these aspects of care resulting in

- the improved patient outcomes that we observe. And - next, these populations have a disease burden that's - higher than those that are less socially vulnerable. - They have higher incidence of tobacco use, air - pollution exposure, - obesity and diabetes, hypertension and coronary disease, just - to name a few. - So fully accountable care models require sophisticated population - risk stratification - technology - and intensive disease management programs - that reduce these preventable - ED visits and admissions.

- And similarly, these patients have very high readmission - rates, and all of these things can be - avoided by programs including transitions of care and - care in the home post discharge. - And, Ken, I think what was interesting when - I read through the study myself is that - when you ran the same analysis - on dually eligible beneficiaries as a as a - sensitivity check, the effect was much smaller than - in the non dual population. And so - it seems like this is also highlighting highlighting - important differences between

- dually eligible beneficiaries and other socially vulnerable populations. - And so - going off of what you just said about, - the the importance of building infrastructure around these - specific - populations to support them, What do you think - health care organizations overall that that serve these - patients, - what can they learn from these differences, - when it comes to designing support systems for - for these specific kinds of patients? - So, - we'll spend a little bit of time talking

- about the infrastructure - in in just a moment because I really - think that's a foundationally important point. But you - you bring up a really, important observation about - this study. We specifically excluded duals from this - population. - And the reason we did so is that - duals have - a separate set of interventions that you can - apply to that population, - that the, socially vulnerable populations - that aren't in duals cannot avail themselves of. - And that's important that the duals population is - 19% of Medicare, but counts for 35% of

- the spend with rates that are rapidly going - up. And interestingly, of the five studies that - we did, - the greatest improvements when you're comparing Medicare Advantage - to traditional Medicare - were actually seen when we looked at that - dually eligible population. - For example, hospital admissions and readmissions were 2433% - lower relative to TM. So so huge, huge - differences. - And I think that, - the striking differences - are - related to a couple of things. One is

- the skill set of the physicians managing these - patients, and we'll talk about that a little - bit later as well. - But also duals have a specific infrastructure - that addresses health related social needs that no - other, - Medicare Advantage program has. - And then patients that are in MA D - SNP plans - have a whole another set of care interventions - that aren't available in traditional Medicare Advantage. - So that duals population, we've really been able - to focus, - so much - resource upon that we're driving very, very significant

- improvements in that population. - Understood. And so, Ken, let's let's dive into - what you just mentioned, the infrastructure and the - capabilities that - organizations need in place to improve outcomes - for high risk populations. - The paper pointed to things like population risk - stratification, - case management, - integrated behavioral health, and social work support as - likely drivers. - But as I understand, it wasn't designed to - isolate which piece - matters most.

- So can you talk a little bit about - that, some of the the infrastructure and capabilities - needed, - in place here to improve outcomes? - That's a critical element. And and, frankly, - as I mentioned, we believe that most of - the improvements that we see when we compare, - Medicare Advantage to traditional Medicare come from that - infrastructure. - So that that full medical management infrastructure - begins with active patient outreach - and sophisticated - population health risk stratification.

- A significant part of this infrastructure, therefore, are - the IT and the tech components. - For example, within OptumHealth, we use AI driven - large language models for our population risk stratification - infrastructure. - We can identify those at high risk for - admission, - frailty. We can look at fall risk, polypharmacy - risk, - and we have highly accurate models of disease - progression for diabetes, COPD, heart failure, and chronic - kidney disease. - This infrastructure then moves to early engagement

- with disease management capabilities, - including RNs, respiratory therapists, - embedded pharmacists and behavioral health professionals, - social workers, and community health workers among others. - And then when patients experience serious illness, care - then moves to the inpatient and sniff, - facilities. - And here, wherein many of our OptumHealth markets, - we have our own hospitalists, our own sniff - providers, - and they work hand in glove with our - care management teams.

- When patients are discharged, we provide robust care - in the home. - So in short, when you think about this - holistic environment that is necessary to manage fully - accountable care models, - success requires that you engage your patients at - every point in their care journey. - And as you can imagine, this is costly. - And the funding of this infrastructure - can only come from the revenue that is - saved by providing better and more efficient care. - This possibility - to repurpose that revenue exists in Medicare Advantage,

- but traditional Medicare doesn't provide the funding for - this infrastructure, - and this accounts for much of the difference - that we think we're seeing in our studies. - So, Ken, when we started our conversation today, - you had mentioned that this is now the - the fifth study in your series with America's - Physicians - physician groups, - and that follows the the fee for service, - Medicare Advantage, traditional Medicare spillover, - and dually eligible comparisons. - So, - can I ask you to step back for - a minute and reflect across your entire body

- of work? - What do you think is the clearest message - the industry should take away from from all - of this research that you've done? - I think the defining message - is that when physicians and physician organizations - take accountability for the total cost of care, - patient outcomes and total cost of care both - improve. - CMS and CMMI appreciate this, and that's exactly - where they're going with advanced track MSSP and - the new ACO lead model.

- And once you understand this, you then need - to ask, why are the outcomes better? - And I believe that there are three main - components to the model success. - First and - and problematically, - traditional Medicare pays exactly the same for high - value care and low value care. - And we won't be successful in expunging low - value care from our health care system until - we stop paying for it. - Fully accountable care models are disincented from providing - low value care. It's a really important point.

- Second point is the infrastructure that I just - described, and it's funded in the full risk - MA model, but not in traditional Medicare. - And then the third, I hinted about just - a moment ago, and that's the skill set - of the physicians who practice in these full - risk models. - Recall that around 30% of care delivered in - this country doesn't improve health outcomes or quality - of life. - At best, this is wasted care, but quite - often, it's it's frankly harmful care. - If you can eliminate that one third of - care, - think about the resources you can then deploy

- to those who will benefit. - And physicians that are practicing in fully accountable - care models have been educated around best evidence - based medicine. - They tend to not over order tests and - procedures. - They try to refer to the highest performing - specialists who practice at the most efficient sites - of service, - and they pay attention to drug costs. - One of the papers that you alluded to - in this series was was a fascinating - exploration of this impact. - We refer to spillover - when interventions in one cohort of patients spillover

- into other cohorts. - And our spillover paper documents how the skill - set acquired - when patients are caring for full risk patients - actually improves outcomes in traditional Medicare. - So in this study, we looked at quality - and efficiency outcomes in two cohorts - of traditional Medicare patients. There was no MA - in this study, so both cohorts were traditional - Medicare. - However, one cohort was cared for by PCPs - who were highly experienced in full risk MA,

- and the second cohort was cared for by - the broad US primary care population. - Relative to that broad PCP - population, - the risk experienced PCPs provided significantly better care - to their traditional Medicare patients - despite there being no incentive to do this. - It was just the care management, that skill - set that they had learned and adopted for - risk - now being applied to traditional Medicare because physicians - tend to treat all of their patients equally. - For example, in that study, eight of nine

- of the causes for preventable hospital admission - were on average about ten to fifteen percent - lower in the risk experienced physicians. - Also, ED visits, - overall hospital admissions and hospital readmissions - were also significantly lower in the risk experienced - physicians, - again in that ten percent to fifteen percent - lower range. - And lastly, in that study, we saw that - overall office visits were 62% - higher - and annual wellness visits were 82% higher. So

- remembering that all of these patients were in - traditional Medicare, - these benefits accrued directly to CMS as a - result of the risk experience physicians patient management. - If every PCP in The US practice the - same patterns as these risk experienced physicians, - the savings to CMS would literally be in - the tens of billions of dollars yearly. - Wow. I mean, there's just some amazing numbers - you decided there, Ken. And, going back to - what you just said at the start of - your answer there in terms of CMS pushing - toward full accountability for all beneficiaries,

- by the end of the decade, 2030, - it's not that far away. And so as - we see the industry continue to move toward - greater accountability for outcomes and and total cost - of care, - Your your final thoughts for us, and for - the health care leaders listening in about how - they should be applying your findings to the - future of care delivery, - for for patients and members all across the - country? - Well, we could spend another podcast on that - topic, but, yeah, I'll I'll try to just,

- give a few examples. I I think - first is the development - of the necessary infrastructure, - which is infrequently - present when physician groups and health systems are - not participating in full risk models. - Next, as I touched on, is the elimination - of wasted and harmful care. - And as I mentioned, this is 30% of - our spend. So I'll give just a one - really quick example of this. - Patients presenting with suspected coronary disease - can be evaluated by various forms of stress - testing, which we've been doing for years,

- or they can undergo a new test known - as a coronary CTA with FFR - that uses a standard CAT scan but has - an AI software enhancement. - One of the most frequently used stress tests - today utilizes a PET scan and is reimbursed - in Medicare at $1,700. - The coronary CTA that I just mentioned is - less than a third of the cost, - and there is clear evidence from three well - done trials now that it reduces - unneeded heart catheterizations - by up to seventy five percent

- and unnecessary coronary stents by up to forty - percent. - And yet nationwide, - less than fifteen percent of coronary evaluations are - currently done using CCA. - So when you think about this applied to - every specialty, there is just an enormous opportunity. - Next, we need to redesign specialty care. - Primary care has been practicing accountable care for - well over a decade now. However, ninety three - percent of specialists are paid straight fee for - service, and we have largely disenfranchised - them from value based care.

- Within OptumHealth, we've begun to measure and transparently - report on quality and cost outcomes at the - level of every individual specialty, - and we are now beginning to change the - compensation models to include a component that is - calculated - from their individual value based care performance. - This would dramatically advance the success of fully - accountable care models if this was widely scaled. - And I think the last point is that - CMS and CMMI, - as I mentioned, are on a path that - will likely lead to mandatory full risk models

- in order to meet their 2030 goal - of having all traditional Medicare beneficiaries - and fully accountable care models. - Healthcare leaders who have stayed on the sidelines - up till now - need to understand that future success will be - difficult - unless they quickly engage and develop the core - competencies - that are necessary - to manage patients in a full risk environment. - I think that's a fantastic - great last piece of advice, - to leave things on, doctor Cohen, - that the health care leaders who who may

- have been sitting on the sidelines - need to get involved now, because it will - certainly not get any easier. So I wanna - thank you for taking the time to join - me here on the podcast - for breaking down this very important research for - our listeners, - and making it easy for for us all - to understand. Really appreciate you taking the time - to do so, Ken. - Great to be with you today, Jacob. Thank - you. And to our listeners, if you'd like - to listen to more podcasts from Becker's Healthcare, - you can visit beckershospitalreview.com.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Payment Integrity Can Protect Savings Without Creating More Friction

    Nov 20, 202619 minAudio

    In this episode, Jon Grandstaff, Senior Vice President of Payment Integrity at Zelis, discusses how payers can reduce payment friction, use AI to support more accurate claims reviews and improve payer-provider...

    Credit the people on this episode

  2. From Learning Collaborative to Gap Closure: How Wisconsin Medicaid Is Telethinking Colorectal Cancer Screening

    Nov 19, 202612 minAudio

    In this episode, Amy Conlon, MPH, Population Health Sr. Manager at Exact Sciences, and Jeff Huebner, MD, FAAFP, Executive Medical Officer, Division of Medicaid Services, Wisconsin Department of Health Services, discuss...

    Credit the people on this episode

  3. What Health Plans Miss When They Look at Markets in Isolation

    Nov 18, 202617 minAudio

    In this episode, Denis Mrkva, Senior Vice President of Analytics Solutions at Data Axle, discusses how health plans can combine consumer, employer, geographic and healthcare data to identify growth opportunities, reduce...

    Credit the people on this episode

  4. Strengthening Provider Networks Through AI, Data and Strategic Partnerships

    Nov 17, 20268 minAudio

    In this episode, Bob Tavernier, Solutions Executive at Quest Analytics®, discusses how health plans can leverage AI, provider data and strategic partnerships to improve network accuracy, strengthen regulatory compliance...

    Credit the people on this episode

  5. Martina Lee Strickland, Head of Marketing, PR and Brand at Clever Care Health Plan

    Nov 16, 202617 minAudio

    In this episode, Martina Lee Strickland, Head of Marketing, PR and Brand at Clever Care Health Plan, joins the podcast to discuss the importance of building trust when serving underserved communities. She also shares...

    Credit the people on this episode